David Neskey to Molecular Targeted Therapy
This is a "connection" page, showing publications David Neskey has written about Molecular Targeted Therapy.
Connection Strength
0.174
-
Immune Evasion by Head and Neck Cancer: Foundations for Combination Therapy. Trends Cancer. 2019 04; 5(4):208-232.
Score: 0.149
-
Chk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53. Mol Cancer Ther. 2013 Sep; 12(9):1860-73.
Score: 0.025